首页|期刊导航|Cancer Innovation|Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
Ying Gong Wanying Lin Xuechun Fang Ruyi Zhang Min Luo Haoran Wu Shuai Chu Chuangkun Li Yiming Peng Zhiyan Piao Siping Wu Junhao Li ZongZhong He Haixia Li Hongxia Wang
Cancer Innovation2025,Vol.4Issue(4):P.11-33,23.
Cancer Innovation2025,Vol.4Issue(4):P.11-33,23.DOI:10.1002/cai2.70018
Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
摘要
关键词
CAR-T therapy/checkpoint inhibitor/glioblastoma/immunotherapy/tumor microenvironment分类
医药卫生引用本文复制引用
Ying Gong,Wanying Lin,Xuechun Fang,Ruyi Zhang,Min Luo,Haoran Wu,Shuai Chu,Chuangkun Li,Yiming Peng,Zhiyan Piao,Siping Wu,Junhao Li,ZongZhong He,Haixia Li,Hongxia Wang..Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions[J].Cancer Innovation,2025,4(4):P.11-33,23.基金项目
supported by the National Natural Science Foundation of China(82004105,82002218,and 82202978) (82004105,82002218,and 82202978)
President''s Fund of Nanfang Hospital,Southern Medical University(2022B041 and 2024B031) (2022B041 and 2024B031)
the Outstanding Youths Development Scheme of Nanfang Hospital,Southern Medical University(2024J007). (2024J007)